| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.06 |